Search - Inserm - Institut national de la santé et de la recherche médicale Access content directly

Filter your results

6 Results
authFullName_s : Sophie Park
Image document

Efficacy of Azacitidine in Autoimmune and Inflammatory Disorders associated with Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia

Jean-Baptiste Fraison , Arsène Mekinian , Eric Grignano , Jean-Emmanuel Kahn , Jean-Benoit Arlet , et al.
Leukemia Research, 2016, 43, pp.13-17. ⟨10.1016/j.leukres.2016.02.005⟩
Journal articles hal-01278608v1
Image document

A variant erythroferrone disrupts iron homeostasis in SF3B1-mutated myelodysplastic syndrome

Sabrina Bondu , Anne-Sophie Alary , Carine Lefevre , Alexandre Houy , Grace Jung , et al.
Science Translational Medicine, 2019, 11 (500), pp.eaav5467. ⟨10.1126/scitranslmed.aav5467⟩
Journal articles inserm-02449216v1

Luspatercept (RAP-536) modulates oxidative stress without affecting mutation burden in myelodysplastic syndromes

Meunier Mathieu , Chloé Friedrich , Nicolas Ducrot , Johanna Zannoni , Tondeur Sylvie , et al.
Annals of Hematology, 2022, 101 (12), pp.2633-2643. ⟨10.1007/s00277-022-04993-7⟩
Journal articles inserm-03874959v1

Results from a prospective, open-label, phase II trial of bendamustine in refractory or relapsed T-cell lymphomas: the BENTLY trial.

Gandhi Damaj , Rémy Gressin , Krimo Bouabdallah , Guillaume Cartron , Bachra Choufi , et al.
Journal of Clinical Oncology, 2013, 31 (1), pp.104-10. ⟨10.1200/JCO.2012.43.7285⟩
Journal articles inserm-00868869v1
Image document

Impact of azacitidine before allogeneic stem-cell transplantation for myelodysplastic syndromes: a study by the Société Française de Greffe de Moelle et de Thérapie-Cellulaire and the Groupe-Francophone des Myélodysplasies.

Gandhi Damaj , Alain Duhamel , Marie Robin , Yves Beguin , Mauricette Michallet , et al.
Journal of Clinical Oncology, 2012, 30 (36), pp.4533-40. ⟨10.1200/JCO.2012.44.3499⟩
Journal articles inserm-00821506v1
Image document

Dyserythropoiesis evaluated by the RED score and hepcidin:ferritin ratio predicts response to erythropoietin in lower-risk myelodysplastic syndromes

Sophie Park , Olivier Kosmider , Fréderic Maloisel , Bernard Drénou , Nicolas Chapuis , et al.
Haematologica, 2019, 104 (3), pp.497-504. ⟨10.3324/haematol.2018.203158⟩
Journal articles hal-02351432v1